ISRCTN85066174
Completed
Not Applicable
Botulinum Toxin in the management of spasticity in children with cerebral palsy: a randomised double blind trial
HS R&D Regional Programme Register - Department of Health (UK)0 sites0 target enrollmentJanuary 23, 2004
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Cerebral palsy
- Sponsor
- HS R&D Regional Programme Register - Department of Health (UK)
- Status
- Completed
- Last Updated
- 11 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Children with spastic diplegia or hemiplegia
Exclusion Criteria
- •Not provided at time of registration
Outcomes
Primary Outcomes
Not specified
Similar Trials
Unknown
Not Applicable
The Efficacy of Botulinum Toxin in Spastic Neuropathic BladderSpastic Neurogenic BladderNCT03407183AHMED FARAHAT HASSAN20
Recruiting
Phase 4
Efficacy of botulinum toxin in pediatric spasticity: a randomized trial comparing 2- to 4- sites hamstring injectioSpastic Cerebral palsyCerebral palsyMuscle SpasticityBotulinum ToxinsTCTR20150803003Thammasat University80
Completed
Not Applicable
Efficiency of Botulinum Toxin Injection for Spastic Equinovarus Foot in Post Stroke Hemiparetic PatientsSpastic Equinovarus FootNCT03405948Assistance Publique Hopitaux De Marseille84
Completed
Phase 4
Botulinum toxin for treating calf muscle spasticity in Hereditary Spastic Paraparesis (HSP): functional effects on dynamic balance and gaitHereditary Spastic Paraparesishereditary spasticity of the lower limbs1002929910041543NL-OMON32926niversitair Medisch Centrum Sint Radboud20
Active, not recruiting
Phase 1
Botulinum toxin for treating calf muscle spasticity in Hereditary Spastic Paraparesis (HSP): functional effects on dynamic balance and gait - FEBOCHSubjects with hereditary spastic paraparesis (HSP)MedDRA version: 9.1Level: LLTClassification code 10019903Term: Hereditary spastic paraplegiaEUCTR2009-012073-34-NLRadboud University Nijmegen Medical Centre20